As the new year approaches, we look back with gratitude for yet another year packed with scientific breakthroughs in children’s health. Continuing a remarkable run for personalized gene therapies, 2018 marked the European Commission’s approval of two gene therapies pioneered at Children’s Hospital of Philadelphia and the University of Pennsylvania, as patients in the European Union (EU) may now be treated with chimeric antigen receptor (CAR)-T cell therapy for aggressive forms of leukemia, and the very first gene therapy developed for inherited blindness.
Tag Archive: PolicyLab
Leading the charge to develop new, targeted approaches to treat disease, Children’s Hospital of Philadelphia Research Institute investigators have uncovered more of the mechanistic underpinnings of the migratory T cell response, and CHOP announced the inaugural Patricia Brophy Endowed Chair in Neuroblastoma Research to advance innovation into less toxic treatment options for specific cancers. Out in the community, CHOP has teamed up with the Philadelphia Housing Development Corporation for the pilot program of its Healthier Together initiative, and researchers are learning how best to help survivors of violence after they are discharged from the hospital.
It’s that time of year, again! Can you believe it? Before you get caught up in yards of wrapping paper, strings of lights, and mile-long “to-do” lists, take a moment to read this week’s roundup of research news from Children’s Hospital of Philadelphia. You’ll discover best-practices to get toddlers to sleep — and stay asleep — just in time for the holidays! Learn the identity of our sweeter-than-sugar doctor, the correlation of lower blood pressure and smoke-free policies, and the latest on Leigh Syndrome.
PolicyLab hosted a 10th anniversary celebration Oct. 22 that its attendees won’t forget. After more than a decade of working to inform policies impacting children’s health, the Center of Emphasis at Children’s Hospital of Philadelphia gathered regional and national leaders alongside clinicians, academics, and community collaborators at the National Museum of American Jewish History in Philadelphia to discuss the future of children’s health policy and practice.
As we move full-speed ahead into fall, the new season brings with it a handful of headlines from our researchers at Children’s Hospital of Philadelphia. This week, we share the latest news about investigators who have been recognized for their research legacies and for their current cutting-edge work, from discoveries in the basic and clinical science of HIV/AIDS, to the development of learning health system-based training in outcomes research, to the design of innovative approaches to childhood cancer.
Editor’s Note: September marks National Suicide Prevention Awareness Month, a time to recognize and promote the different ways that we as a community can help prevent suicide. At PolicyLab, a Center of Emphasis at Children’s Hospital of Philadelphia Research Institute, our researchers study the key role that hospitals, schools, health systems, and other community institutions play in safeguarding the mental health of children and adolescents. In this guest blog post, originally appearing on PolicyLab’s blog, Stephanie Doupnik, MD, MSHP, a faculty member at PolicyLab, co-director of the inpatient Medical Behavioral Unit at CHOP, and an instructor of Pediatrics at the University of Pennsylvania, discusses her four-year research project to identify the most effective suicide prevention practices for young people hospitalized for a suicide attempt.
Regional and national leaders in children’s health policy will convene in Old City, Philadelphia Oct. 22 to celebrate the 10th anniversary of PolicyLab, a Center of Emphasis at Children’s Hospital of Philadelphia Research Institute. Never one to sit on the sidelines, PolicyLab has evolved over the last decade to become an energetic force in evidence-to-action reform, shaping the policies and practices that impact the health and well-being of children and families across the country.
It’s still a month before teachers and students are officially back to school, but here at Children’s Hospital of Philadelphia Research Institute, you can learn something new every day. In this edition of our biweekly news roundup, discover the latest findings from our ophthalmologists on how clinicians should choose to screen premature babies for a potentially blinding eye disorder, find out how CRISPR-based technology allowed scientists to reveal insights into sickle cell disease, and prepare for an educational and exciting speech from the recently announced keynote speaker at PolicyLab’s upcoming 10th Anniversary Forum
In this week’s roundup of headlines at Children’s Hospital of Philadelphia, our research takes a leap into real-world applications. Learn how a study from ear, nose, and throat experts at CHOP helped to inform new button battery injury guidelines from the National Poison Center, why a software tool that mines through genomics data can improve genetic diagnoses, and what PolicyLab plans to achieve at their upcoming 10thanniversary forum, “Charting New Frontiers in Children’s Health Policy and Practice.” Don’t miss a chance to discover the latest in research news!
Editor’s Note: This guest blog by David Rubin, MD, MSCE, and Kathleen Noonan, JD, co-founders of PolicyLab at Children’s Hospital of Philadelphia, originally appeared on the PolicyLab website as the first in a series of blog posts that will be published throughout the year in recognition of PolicyLab's 10th anniversary. We invite you to check the PolicyLab website in the months to come for more about their ongoing efforts to chart new frontiers in children's health research and policy.